ANAB
$46.61-4.31%
AnaptysBio Inc.Stock · HealthcareRussell 2000 0.04%Nasdaq Composite 0.004%Russell 3000 0.003%US Stock Market 0.002%
ANAB financial statements
The full income statement, balance sheet, and cash-flow statement for AnaptysBio Inc. (ANAB), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 27.4M2024-09 30.4M2024-12 30.7M2025-03 29.4M2025-06 28.0M2025-09 27.7M2025-12 28.7M2026-03 29.1M2026-06 29.9M+8.9% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 235M+157.0% | 91.3M+432.0% | 17.2M+66.8% | 10.3M-83.7% | 63.2M-15.8% | |
| 7.70M-69.4% | 25.1M-86.2% | 182M+44.7% | 125M+4.5% | 120M+21.3% | ||
| Research & development | 136M-17.0% | 164M+23.9% | 132M+49.0% | 88.8M-9.8% | 98.5M+23.1% | |
| Selling, general & administrative | 11.3M-16.8% | 13.6M-67.5% | 41.9M+14.5% | 36.6M+70.5% | 21.5M+14.0% | |
| General & administrative | 11.3M-16.8% | 13.6M-67.5% | 41.9M+14.5% | 36.6M+70.5% | 21.5M+14.0% | |
| Operating income | 227M+243.0% | 66.2M+140.2% | -164M-42.8% | -115M-102.7% | -56.8M-137.9% | |
| Interest expense | — | — | — | — | 0.00 | |
| Other non-operating income | 5.45M | 0.00+100.0% | -2.00K-116.7% | 12.0K-67.6% | 37.0K+436.4% | |
| Pre-tax income | 162M+421.1% | 31.1M+119.0% | -164M-27.1% | -129M-122.7% | -57.8M-190.0% | |
| Income tax | 772K+388.6% | 158K+4050.0% | -4.00K-116.7% | 24.0K | 0.00 | |
| -13.2M+90.9% | -145M+11.2% | -164M-27.1% | -129M-122.7% | -57.8M-190.0% | ||
| Income from continuing operations | 162M+421.3% | 31.0M | — | — | — | |
| Discontinued operations | -175M+0.8% | -176M | — | — | — | |
| -$0.44+91.1% | -$4.92+19.1% | -$6.08-33.0% | -$4.57-116.6% | -$2.11-189.0% | ||
| EPS (basic) | -$0.46+91.0% | -$5.12+15.8% | -$6.08-33.0% | -$4.57-116.6% | -$2.11-189.0% | |
| Weighted-avg shares (basic) | 28.8M+1.3% | 28.4M+5.4% | 26.9M-4.4% | 28.2M+2.7% | 27.4M+0.5% | |
| Weighted-avg shares (diluted) | 30.2M+2.3% | 29.5M+9.7% | 26.9M-4.4% | 28.2M+2.7% | 27.4M+0.5% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 350M-18.9% | 432M+6.2% | 407M-9.0% | 447M-19.3% | 554M+39.7% | ||
| Cash & equivalents | 138M+498.8% | 23.1M-35.8% | 36.0M-49.6% | 71.3M-85.6% | 496M+97.9% | |
| Accounts receivable | 33.9M-17.0% | 40.8M+495.0% | 6.85M+382.8% | 1.42M+62.0% | 876K | |
| Prepaid expenses | 0.00-100.0% | 1.18M-87.0% | 9.08M+99.8% | 4.54M-7.3% | 4.90M+68.6% | |
| 364M-24.7% | 484M+7.0% | 452M-25.9% | 610M-5.1% | 643M+54.4% | ||
| Property, plant & equipment | 111K-15.3% | 131K-93.8% | 2.10M+0.4% | 2.09M-8.5% | 2.28M+28.0% | |
| Operating lease right-of-use | 12.5M-13.0% | 14.4M-11.1% | 16.2M-9.6% | 17.9M-8.5% | 19.6M+5585.5% | |
| Deferred tax assets | 0.00 | 0.00 | — | — | — | |
| Other non-current assets | 256K+0.0% | 256K+0.0% | 256K+0.0% | 256K+0.0% | 256K-0.8% | |
| 38.6M-15.0% | 45.4M+21.3% | 37.4M+43.7% | 26.1M+61.8% | 16.1M-18.8% | ||
| Accounts payable | 3.87M-3.3% | 4.00M-14.8% | 4.70M+68.8% | 2.78M+59.9% | 1.74M-58.7% | |
| Accrued liabilities | 32.7M-17.3% | 39.5M+27.6% | 31.0M+43.1% | 21.6M+68.3% | 12.9M-15.8% | |
| Current lease liability | 2.08M+8.1% | 1.93M+8.3% | 1.78M+8.6% | 1.64M+8.8% | 1.50M+340.1% | |
| Non-current lease liability | 12.0M-14.7% | 14.1M-12.0% | 16.0M-10.0% | 17.8M-8.4% | 19.4M | |
| Operating lease liability (total) | 14.1M-12.0% | 16.0M-10.0% | 17.8M-8.4% | 19.4M-7.2% | 21.0M+6027.2% | |
| 37.2M-47.5% | 70.9M-19.6% | 88.1M-66.4% | 262M-26.5% | 356M-10.2% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 28.0K-6.7% | 30.0K+11.1% | 27.0K-6.9% | 29.0K+3.6% | 28.0K+3.7% | |
| Additional paid-in capital | 810M-2.4% | 830M+18.1% | 703M-2.1% | 718M+5.8% | 679M+2.7% | |
| Retained earnings | -773M-1.7% | -759M-23.6% | -614M-36.3% | -450M-40.0% | -322M-21.9% | |
| Accumulated other comprehensive income | -24.0K-107.9% | 305K+138.3% | -797K+84.8% | -5.25M-1143.1% | -422K-10450.0% | |
| Total liabilities & equity | 364M-24.7% | 484M+7.0% | 452M-25.9% | 610M-5.1% | 643M+54.4% | |
| Common shares issued | 28.0M-8.1% | 30.5M+14.6% | 26.6M-6.7% | 28.5M+3.1% | 27.6M+1.1% | |
| Common shares outstanding | 28.0M-8.1% | 30.5M+14.6% | 26.6M-6.7% | 28.5M+3.1% | 27.6M+1.1% | |
| Shares outstanding (cover) | 28.7M-6.3% | 30.7M+14.6% | 26.8M-4.2% | 27.9M+0.9% | 27.7M+1.1% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 19.7M+114.6% | -135M-12.0% | -121M-64.1% | -73.6M-60.3% | -45.9M-224.4% | ||
| Depreciation & amortization | 20.0K+0.0% | 20.0K-96.9% | 652K-3.4% | 675K+9.0% | 619K+10.7% | |
| Share-based compensation | 3.77M-47.8% | 7.22M-78.3% | 33.2M+21.4% | 27.4M+78.2% | 15.3M | |
| Deferred income taxes | 0.00 | 0.00 | — | — | — | |
| 228M+627.1% | 31.4M-78.3% | 145M+136.7% | -395M-1116.7% | 38.8M-58.9% | ||
| Capital expenditure | 87.0K-75.7% | 358K-55.6% | 807K+125.4% | 358K-73.8% | 1.37M+140.1% | |
| Free cash flow | 19.6M+114.5% | -136M-11.6% | -122M-64.4% | -74.0M-56.4% | -47.3M-221.1% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Proceeds from sale of PP&E | — | — | 0.00 | 0.00-100.0% | 15.0K | |
| -133M-204.4% | 127M+314.3% | -59.3M-234.7% | 44.0M-82.6% | 252M+28802.8% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 14.3M+120.3% | 6.47M+161.9% | 2.47M-79.1% | 11.8M+363.3% | 2.55M+414.7% | |
| Common stock repurchased | 68.6M+14949.6% | 456K-99.1% | 50.0M | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | 115M+398.8% | 23.1M+165.3% | -35.3M+91.7% | -424M-273.1% | 245M+208.7% | |
| Interest paid | 80.0M+89.9% | 42.1M | 0.00 | 0.00 | 0.00-100.0% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 929M+243.3% | 271M-28.7% | 379M-35.4% | 587M-8.4% | 641M+63.4% | |
| P/S | 4.0×+33.6% | 3.0×-88.3% | 25.4×-80.6% | 130.8×+1189.2% | 10.1×+94.0% | |
| P/B | 25.0×+553.7% | 3.8×+21.2% | 3.2×+49.0% | 2.1×+17.6% | 1.8×+81.9% | |
| P/FCF | 47.4× | — | — | — | — | |
| FCF yield | 2.1% | — | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ANAB’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ANAB filings on SEC EDGAR → Not investment advice.